Fexofenadine Clinical Trials Fexofenadine RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

A Placebo-controlled Study of 2-day Pre-treatment With Fexofenadine in Seasonal Allergic Rhinitis
Condition:   Seasonal Allergic Rhinitis Interventions:   Drug: Fexofenadine;   Drug: Placebo Sponsor:   Opella Healthcare Group SAS, a Sanofi Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 20, 2023 Category: Research Source Type: clinical trials